Literature DB >> 15548484

Apolipoprotein E genotypes do not influence the age of onset in Huntington's disease.

C Saft1, J E Andrich, N Brune, M Gencik, P H Kraus, H Przuntek, J T Epplen.   

Abstract

OBJECTIVE: The epsilon4 allele of the apolipoprotein E (ApoE) gene has been defined as a critical factor for early onset neurodegeneration in Pick's, Parkinson's, and Alzheimer's disease. Unexpectedly, the epsilon4 allele appeared to delay the age of onset in Huntington's disease (HD) patients. Furthermore, sex specific effects were reported on earlier age of onset due to the ApoE epsilon2epsilon3 genotype in males with HD. The age of onset of HD is known to be negatively correlated with increasing lengths of pathogenetic CAG expansions in the huntingtin gene.
METHODS: In order to examine the effects of CAG block lengths, we have correlated ApoE genotypes with the age of onset in 145 patients symptomatic for HD with psychiatric and somatic symptoms (depression, psychosis, dementia, choreic, and other movement disorders) harbouring only modestly expanded huntingtin alleles (41-45 CAGs).
RESULTS: The negative correlation between age of onset and CAG block length was established in our HD cohort. Statistically significant effects of the epsilon4 allele were not obvious regarding clinical characteristics including age of onset, nor were any sex differences for the epsilon2epsilon3 genotype observed.
CONCLUSION: The ApoE genotype does not affect the course of HD significantly.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15548484      PMCID: PMC1738834          DOI: 10.1136/jnnp.2003.022756

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  21 in total

Review 1.  Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond.

Authors:  R W Mahley; Y Huang
Journal:  Curr Opin Lipidol       Date:  1999-06       Impact factor: 4.776

2.  Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats.

Authors:  D C Rubinsztein; J Leggo; R Coles; E Almqvist; V Biancalana; J J Cassiman; K Chotai; M Connarty; D Crauford; A Curtis; D Curtis; M J Davidson; A M Differ; C Dode; A Dodge; M Frontali; N G Ranen; O C Stine; M Sherr; M H Abbott; M L Franz; C A Graham; P S Harper; J C Hedreen; M R Hayden
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

3.  Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a 'thrifty' allele?

Authors:  R M Corbo; R Scacchi
Journal:  Ann Hum Genet       Date:  1999-07       Impact factor: 1.670

4.  Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length.

Authors:  P Kehoe; M Krawczak; P S Harper; M J Owen; A L Jones
Journal:  J Med Genet       Date:  1999-02       Impact factor: 6.318

5.  Apolipoprotein E polymorphism in Pick's disease and in Huntington's disease.

Authors:  J Kálmán; A Juhász; K Majtényi; A Rimanóczy; K Jakab; G Gárdián; I Raskó; Z Janka
Journal:  Neurobiol Aging       Date:  2000 Jul-Aug       Impact factor: 4.673

6.  A one-hit model of cell death in inherited neuronal degenerations.

Authors:  G Clarke; R A Collins; B R Leavitt; D F Andrews; M R Hayden; C J Lumsden; R R McInnes
Journal:  Nature       Date:  2000-07-13       Impact factor: 49.962

7.  Apolipoprotein E and presenilin-1 genotypes in Huntington's disease.

Authors:  M Panas; D Avramopoulos; G Karadima; M B Petersen; D Vassilopoulos
Journal:  J Neurol       Date:  1999-07       Impact factor: 4.849

Review 8.  Treatment of the psychiatric manifestations of Huntington's disease: a review of the literature.

Authors:  I Leroi; M Michalon
Journal:  Can J Psychiatry       Date:  1998-11       Impact factor: 4.356

9.  The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease.

Authors:  S E Andrew; Y P Goldberg; B Kremer; H Telenius; J Theilmann; S Adam; E Starr; F Squitieri; B Lin; M A Kalchman
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

10.  Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/apolipoprotein E genotype.

Authors:  R Krüger; A M Vieira-Saecker; W Kuhn; D Berg; T Müller; N Kühnl; G A Fuchs; A Storch; M Hungs; D Woitalla; H Przuntek; J T Epplen; L Schöls; O Riess
Journal:  Ann Neurol       Date:  1999-05       Impact factor: 10.422

View more
  13 in total

Review 1.  Interventions for heart disease and their effects on Alzheimer's disease.

Authors:  Benjamin Wolozin; Martin M Bednar
Journal:  Neurol Res       Date:  2006-09       Impact factor: 2.448

2.  Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds.

Authors:  J M Andresen; J Gayán; S S Cherny; D Brocklebank; G Alkorta-Aranburu; E A Addis; L R Cardon; D E Housman; N S Wexler
Journal:  J Med Genet       Date:  2006-10-03       Impact factor: 6.318

Review 3.  Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy.

Authors:  Chia-Chen Liu; Chia-Chan Liu; Takahisa Kanekiyo; Huaxi Xu; Guojun Bu
Journal:  Nat Rev Neurol       Date:  2013-01-08       Impact factor: 42.937

Review 4.  HDL and cognition in neurodegenerative disorders.

Authors:  David A Hottman; Dustin Chernick; Shaowu Cheng; Zhe Wang; Ling Li
Journal:  Neurobiol Dis       Date:  2014-08-13       Impact factor: 5.996

Review 5.  Apolipoprotein E alleles can contribute to the pathogenesis of numerous clinical conditions including HSV-1 corneal disease.

Authors:  James M Hill; Partha S Bhattacharjee; Donna M Neumann
Journal:  Exp Eye Res       Date:  2006-09-26       Impact factor: 3.467

Review 6.  Huntington's Disease: Relationship Between Phenotype and Genotype.

Authors:  Yi-Min Sun; Yan-Bin Zhang; Zhi-Ying Wu
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

7.  NR2A and NR2B receptor gene variations modify age at onset in Huntington disease in a sex-specific manner.

Authors:  Larissa Arning; Carsten Saft; Stefan Wieczorek; Jürgen Andrich; Peter H Kraus; Jörg T Epplen
Journal:  Hum Genet       Date:  2007-06-14       Impact factor: 4.132

Review 8.  Nosology and Phenomenology of Psychosis in Movement Disorders.

Authors:  Malco Rossi; Nicole Farcy; Sergio E Starkstein; Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2020-01-07

9.  Function and comorbidities of apolipoprotein e in Alzheimer's disease.

Authors:  Valérie Leduc; Dorothée Domenger; Louis De Beaumont; Daphnée Lalonde; Stéphanie Bélanger-Jasmin; Judes Poirier
Journal:  Int J Alzheimers Dis       Date:  2011-04-05

10.  Huntington's disease: the case for genetic modifiers.

Authors:  James F Gusella; Marcy E MacDonald
Journal:  Genome Med       Date:  2009-08-21       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.